Table of Contents
As filed with the Securities and Exchange Commission
on October 30, 2024
Registration No. 333-
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM
S-8
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
PAYSIGN,
INC.
(Exact name of registrant as specified in its charter)
|
Nevada |
|
95-4550154 |
(State or other jurisdiction of
incorporation or organization) |
|
(I.R.S. Employer
Identification No.) |
2615 St. Rose Parkway
Henderson, Nevada 89052
(Address of Principal Executive Offices) (Zip Code)
PAYSIGN, INC. 2023 EQUITY
INCENTIVE PLAN
(Full Title of the Plan)
Mark R. Newcomer
Chief Executive Officer
Paysign, Inc.
2615 St. Rose Parkway
Henderson, Nevada 89052
(Name and Address of Agent for Service)
(702) 453-2221
(Telephone Number, Including Area Code, of Agent
for Service)
Copy to:
Brian H. Blaney, Esq.
Katherine A. Beck, Esq.
Greenberg Traurig, LLP
2375 E. Camelback Road, Suite 800
Phoenix, Arizona 85016
(602) 445-8000
Indicate by check mark
whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an
emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller
reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
| Large accelerated filer |
☐ |
Non-accelerated filer ☒ |
Smaller reporting company ☒ |
| Accelerated filer |
☐ |
|
Emerging growth company ☒ |
| |
|
|
|
If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐
EXPLANATORY NOTE
This Registration Statement registers shares of
our common stock, par value $0.001 per share, consisting of (i) 420,000 shares of common stock that will be issued
upon the vesting of restricted stock awards granted under the Paysign, Inc. 2023 Equity Incentive Plan (the “Plan”), and (ii)
160,000 shares reserved for future issuance pursuant to awards that may be granted under the Plan.
This Registration Statement contains two parts.
The first part contains a “reoffer prospectus” prepared in accordance with Part I of Form S-3 (in accordance with Instruction
C of the General Instructions to Form S-8). The reoffer prospectus permits reoffers and resales on a continuous or delayed basis of those
shares referred to above that constitute “restricted securities” or “control securities,” within the meaning of
Form S-8, by certain of our stockholders, as more fully set forth therein. The second part contains information required to be set forth
in the Registration Statement pursuant to Part II of Form S-8.
REOFFER PROSPECTUS
PAYSIGN, INC.
420,000 Shares of Common Stock
This Reoffer Prospectus (this
“Prospectus”) relates to an aggregate of up to 420,000 shares (the “Shares”) of our common stock, par value
$0.001 per share (the “Common Stock”), which may be offered and sold from time to time by certain of our stockholders
(the “Selling Stockholders”) who have acquired or will acquire such Shares pursuant to the vesting of restricted stock
awards issued under the Paysign, Inc. 2023 Equity Incentive Plan (the “Plan”). See “Selling
Stockholders.” This Prospectus covers the offering for resale of (i) shares acquired by the Selling Stockholders prior to
the filing of a Registration Statement on Form S-8 (“Restricted Shares”) and (ii) shares to be acquired by Selling
Stockholders who may be deemed affiliates of our company after the filing of a Registration Statement on Form S-8 pursuant to
restricted stock awards currently held by those Selling Stockholders (“Control Shares”). Our Common
Stock is listed on The Nasdaq Stock Market under the symbol “PAYS.” On October 29, 2024, the last reported sales price
of the our Common Stock on The Nasdaq Stock Market was $3.71 per share.
We will not receive any of the proceeds from sales
of the Shares by any of the Selling Stockholders. The Shares may be offered from time to time by any or all of the Selling Stockholders
(and their donees and pledgees) through ordinary brokerage transactions, in negotiated transactions or in other transactions, at such
prices as the Selling Stockholder may determine, which may relate to market prices prevailing at the time of sale or be a negotiated price.
See “Plan of Distribution.” We will bear all costs, expenses and fees in connection with the registration of the Shares. Brokerage
commissions and similar selling expenses, if any, attributable to the offer or sale of the Shares will be borne by the Selling Stockholder
(or their donees and pledgees).
We are an “emerging growth company”
as defined under the federal securities laws and are subject to reduced reporting requirements.
Investing in our securities involves a high
degree of risk. Before buying any securities, you should carefully read the discussion of the risks of investing in our securities in
“Risk Factors” beginning on page 2 of this Prospectus.
Each Selling Stockholder and any broker executing
selling orders on behalf of a Selling Stockholder may be deemed to be an “underwriter” as defined in the Securities Act of
1933, as amended (the “Securities Act”). If any broker-dealers are used to effect sales, any commissions paid to broker-dealers
and, if broker-dealers purchase any of the Shares as principals, any profits received by such broker-dealers on the resale of the Shares,
may be deemed to be underwriting discounts or commissions under the Securities Act. In addition, any profits realized by the Selling Stockholders
may be deemed to be underwriting commissions.
THESE SECURITIES HAVE NOT BEEN APPROVED OR
DISAPPROVED BY THE SECURITIES AND EXCHANGE COMMISSION OR ANY STATE SECURITIES COMMISSION NOR HAS THE SECURITIES AND EXCHANGE COMMISSION
OR ANY STATE SECURITIES COMMISSION PASSED UPON THE ACCURACY OR ADEQUACY OF THIS PROSPECTUS. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL
OFFENSE.
The date
of this Prospectus is October 30, 2024.
_______________________________________
TABLE OF CONTENTS
You should
rely only on the information contained in this Prospectus or in any accompanying prospectus supplement by us or on our behalf. No person
is authorized to give any information or represent anything not contained or incorporated by reference in this Prospectus or any prospectus
supplement. This Prospectus and any prospectus supplement do not constitute an offer to sell or a solicitation of any offer to buy any
securities in any jurisdiction to any person to whom it is unlawful to make such offer or solicitation in such jurisdiction. The information
contained in this Prospectus or any prospectus supplement, as well as information incorporated by reference, is current only as of the
date of that information. Our business, financial condition and results of operations may have changed since that date.
Unless the
context otherwise requires, all references in this Prospectus to “we,” “us,” “our” or “our company”
refer to Paysign, Inc. and its consolidated subsidiaries.
THE COMPANY
We are a vertically integrated provider of prepaid
card products and processing services for corporate, consumer and government applications. Our payment solutions are utilized by our corporate
customers as a means to increase customer loyalty, increase patient adherence rates, reduce administration costs and streamline operations.
Public sector organizations can utilize our payment solutions to disburse public benefits or for internal payments. We market our prepaid
card solutions under our Paysign® brand. As we are a payment processor and prepaid card program manager, we derive our revenue from
all stages of the prepaid card lifecycle.
We operate on a powerful, high-availability payments
platform with cutting-edge fintech capabilities that can be seamlessly integrated with our clients’ systems. This distinctive positioning
allows us to provide end-to-end technologies that securely manage transaction processing, cardholder enrollment, value loading, account
management, data and analytics, and customer service. Our architecture is known for its cross-platform compatibility, flexibility, and
scalability – allowing our clients and partners to leverage these advantages for cost savings and revenue opportunities.
Our suite of product offerings includes solutions
for corporate rewards, prepaid gift cards, general purpose reloadable debit cards, employee incentives, consumer rebates, donor compensation,
clinical trials, healthcare reimbursement payments and pharmaceutical payment assistance, and demand deposit accounts accessible with
a debit card. In the future, we expect to further expand our product into other prepaid card offerings such as travel cards and expense
reimbursement cards. Our cards are sponsored by our issuing bank partners.
Our revenues include fees generated from cardholder
fees, interchange, card program management fees, transaction claims processing fees, breakage and settlement income. Revenue from cardholder
fees, interchange, card program management fees and transaction claims processing fees is recorded when the performance obligation is
fulfilled. Breakage is recorded ratably over the estimated card life based on historical redemption patterns, market-specific trends,
escheatment rules and existing economic conditions and relates solely to our open-loop gift card business, which began at the end of 2022.
Settlement income is recorded at the expiration of the card program and relates solely to our pharma prepaid business which ended in 2022.
We were incorporated in Nevada on August 24, 1995.
Our principle executive offices are located at 2615 St. Rose Parkway, Henderson, Nevada 89052, and our telephone number is (702) 453-2221.
Our website address is www.paysign.com. Information contained on, or that can be accessed through, our website is not incorporated
by reference into this Prospectus, and you should not consider information on our website to be part of this Prospectus. We qualify as
an “emerging growth company,” as defined in the Jumpstart Our Business Startups Act of 2012, and are subject to reduced reporting
requirements that are otherwise applicable to public companies.
RISK FACTORS
Investing in our Common Stock involves a high
degree of risk. Before investing in our Common Stock, you should carefully consider the risks set forth under the caption “Risk
Factors” in our Annual Report on Form 10-K filed with the Securities and Exchange Commission (the “Commission”) on March
27, 2024, which are incorporated by reference herein, and subsequent reports filed with the Commission, together with the financial and
other information contained or incorporated by reference in this Prospectus. If any of the risks actually occur, our business, results
of operations, financial condition and prospects could be harmed. In that event, the trading price of our Common Stock could decline,
and you could lose part or all of your investment. Additional risks and uncertainties not presently known to us or that we currently deem
immaterial also may impair our business operations.
SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS
Certain statements in this Prospectus may be considered
forward-looking under federal securities laws, and we intend that such forward-looking statements be subject to the safe harbor created
thereby. All statements, besides statements of fact included in this Prospectus are forward-looking. Such forward-looking statements include,
among others:
| · | our belief that our payment solutions are utilized by our corporate customers as a means to increase customer
loyalty, increase patient adherence rates, reduce administration costs and streamline operations; |
| | | |
| · | our belief that public sector organizations can utilize our payment solutions to disburse public benefits
or for internal payments; |
| | | |
| · | our belief that we operate on a powerful, high-availability payments platform with cutting-edge fintech
capabilities that can be seamlessly integrated with our clients’ systems; |
| | | |
| · | our belief that our architecture is known for its cross-platform compatibility, flexibility, and scalability
– allowing our clients and partners to leverage these advantages for cost savings and revenue opportunities; and |
| | | |
| · | our expectation that in the future we will further expand our product into other prepaid card offerings
such as travel cards and expense reimbursement cards. |
We caution that these statements are qualified
by important risks, uncertainties and other factors that could cause actual results to differ materially from those reflected by such
forward-looking statements. Such factors include, among others:
| · | the inability to continue our current growth rate in future periods; |
| | | |
| · | that a downturn in the economy, including as a result of COVID-19 and variants, as well as further government
stimulus measures, could reduce our customer base and demand for our products and services, which could have an adverse effect on our
business, financial condition, profitability and cash flows; |
| | | |
| · | operating in a highly regulated environment; |
| | | |
| · | failure by us or business partners to comply with applicable laws and regulations; |
| | | |
| · | changes in the laws, regulations, credit card association rules or other industry standards affecting
our business; |
| | | |
| · | that a data security breach could expose us to liability and protracted and costly litigation; and |
| | | |
| · | other risk factors set forth in our Annual Report on Form 10-K for the year ended December 31, 2023. |
Except to the extent required by federal securities
laws, we undertake no obligation to publicly update or revise any statements in this Prospectus, whether as a result of new information,
future events or otherwise.
USE OF PROCEEDS
We will not receive any proceeds from the sale
of the Shares by the Selling Stockholders. All proceeds from the sale of the Shares will be for the account of the Selling Stockholders,
as described below. See the sections titled “Selling Stockholders” and “Plan of Distribution.”
SELLING STOCKHOLDERS
This Prospectus relates to Shares that are being
registered for reoffers and resales by Selling Stockholders who have acquired or will acquire such Shares pursuant to the vesting of restricted
stock awards issued under the Plan.
Beneficial ownership is determined in accordance
with the rules of the Commission, is based upon 53,968,374 shares outstanding as of the date of this Prospectus (including the 420,000
Shares issuable upon the vesting of restricted stock awards being registered for resale pursuant to the Registration Statement of which
this Prospectus forms a part), and generally includes voting or investment power with respect to securities. Options to purchase shares
of common stock that are currently exercisable or exercisable within 60 days of the date of this Prospectus are deemed to be outstanding
and to be beneficially owned by the person holding such options for the purpose of computing the percentage ownership of such person but
are not treated as outstanding for the purpose of computing the percentage ownership of any other person. Shares of restricted stock,
whether vested or unvested, are deemed to be outstanding and to be beneficially owned by the person holding such restricted stock for
the purpose of computing the percentage ownership of such person and are treated as outstanding for the purpose of computing the percentage
ownership of each other person.
The inclusion in the table of the individuals
named therein shall not be deemed to be an admission that any such individuals are “affiliates” of our company.
Unless otherwise indicated below, the address
of each Selling Stockholder listed below is c/o Paysign, Inc., 2615 St. Rose Parkway, Henderson, Nevada 89052. Unless otherwise indicated
below, to our knowledge, the Selling Stockholders listed below have sole voting and dispositive power with respect to all such shares
that they beneficially own, subject to community property laws where applicable.
| | |
Shares Beneficially Owned
Prior
to the Offering | | |
Shares
Being Offered(1) | | |
Shares Beneficially Owned
After the Offering(2) | |
| Selling Stockholder | |
Shares | | |
Percentage | | |
Shares | | |
Shares | | |
Percentage | |
| Named Selling Stockholders(3) | |
| 447,476(4) | | |
| * | | |
| 420,000 | | |
| 27,476 | | |
| * | |
___________
* Less
than 1%.
| (1) |
Reflects shares of our Common Stock offered under this Prospectus. |
| (2) |
Assumes that all of the Shares held by each Selling Stockholder and being offered under this Prospectus are sold, and that no Selling Stockholder will acquire additional shares of Common Stock before the completion of this offering. |
| (3) |
Includes the following four named non-affiliate employees, each of whom holds at least 1,000 Shares: Rodney A. Brooks, Cosimo Cambi, Ramandeep Singh, and Hariharan Venkatachalam. Each of these persons beneficially owns less than 1% of our Common Stock. |
| (4) |
Consists
of (i) 13,476 shares of Common Stock and (ii) 434,000 shares of Common Stock issuable upon the vesting of restricted stock awards, including
the 420,000 Shares issuable upon the vesting of restricted stock awards being registered for resale pursuant to the Registration Statement
of which this Prospectus forms a part. |
PLAN OF DISTRIBUTION
The purpose of this Prospectus is to permit the
Selling Stockholders, if they desire, to offer for sale and sell the Shares they acquired or will acquire pursuant to the vesting of restricted
stock awards issued under the Plan at such times and at such places as the Selling Stockholders choose.
The decision to sell any Shares is within the
discretion of the holders thereof, subject generally to our policies affecting the timing and manner of sale of Common Stock by certain
individuals. There can be no assurance that any Shares will be sold by the Selling Stockholders.
Sales of Shares by the Selling Stockholders may
be effected from time to time in one or more types of transactions (which may include block transactions) on The Nasdaq Stock Market,
in the over-the-counter market, in negotiated transactions, through the writing of options on the Shares, through settlement of short
sales of Shares, or a combination of such methods of sale, at market prices prevailing at the time of sale, at fixed prices (which may
be changed) or at negotiated prices. Such transactions may or may not involve brokers or dealers. The Selling Stockholders have advised
us that they have not entered into any agreements, understandings or arrangements with any underwriters or broker-dealers regarding the
sale of their Shares, nor is there an underwriter or coordinating broker acting in connection with the proposed sale of the Shares by
the Selling Stockholders.
The Selling Stockholders may effect such transactions
by selling Shares directly to purchasers or to or through broker-dealers, which may act as agents or principals. Such broker-dealers may
receive compensation in the form of discounts, concessions, or commissions from the Selling Stockholders and/or the purchasers of Shares
for whom such broker-dealers may act as agents or to whom they sell as principal, or both (which compensation as to a particular broker-dealer
might be in excess of customary commissions).
The Selling Stockholders and any broker-dealers
that act in connection with the sale of Shares might be deemed to be “underwriters” within the meaning of Section 2(11) of
the Securities Act, and any commissions received by such broker-dealers and any profit on the resale of the Shares sold by them while
acting as principals might be deemed to be underwriting discounts or commissions under the Securities Act. The Selling Stockholders may
agree to indemnify any agent, dealer or broker-dealer that participates in transactions involving sales of the Shares against certain
liabilities, including liabilities arising under the Securities Act.
Because the Selling Stockholders may be deemed
to be “underwriters” within the meaning of Section 2(11) of the Securities Act, the Selling Stockholders will be subject to
the prospectus delivery requirements of the Securities Act, which may include delivery through the facilities of The Nasdaq Stock Market
pursuant to Rule 153 under the Securities Act.
The Selling Stockholders and any other person
participating in the sale of the Shares will be subject to the Securities Exchange Act of 1934, as amended (the “Exchange Act”).
The Exchange Act rules include, without limitation, Regulation M, which may limit the timing of purchases and sales of any of the Shares
by the Selling Stockholders and any other person. In addition, Regulation M may restrict the ability of any person engaged in the distribution
of the Shares to engage in market-making activities with respect to the particular Shares being distributed. This may affect the marketability
of the Shares and the ability of any person or entity to engage in market-making activities with respect to the Shares.
The Selling Stockholders also may resell all or
a portion of the Shares in open market transactions in reliance upon Rule 144 under the Securities Act, provided they meet the criteria
and conform to the requirements of such Rule.
LEGAL MATTERS
The validity of the Shares being offered hereby
has been passed upon by Greenberg Traurig, LLP, Phoenix, Arizona.
EXPERTS
Our consolidated financial statements as of December 31, 2023 and 2022, and for the years then ended, incorporated in this Prospectus by reference from our Annual Report on
Form 10-K for the year ended December 31, 2023, have been audited by Moss Adams LLP, an independent registered public accounting
firm, as stated in their report. Such consolidated financial statements are incorporated by reference in reliance upon the report of such
firm given their authority as experts in accounting and auditing.
INCORPORATION OF DOCUMENTS BY REFERENCE
The following documents, which we have filed with
the Commission, are incorporated by reference in this Prospectus:
| (a) | Annual Report on Form 10-K for the
year ended December 31, 2023, as filed with the Commission on March 27, 2024; |
| (b) | Quarterly Report on Form 10-Q for the quarter ended March 31, 2024, as filed
with the Commission on May 8, 2024; |
| (c) | Quarterly Report on Form 10-Q for the quarter ended June 30, 2024, as filed with the Commission on August
1, 2024; |
| (d) | Definitive Proxy Statement on Schedule 14A, as filed with the Commission on March 29, 2024; |
| (e) | Current Reports on Form 8-K as filed with the Commission on January 29, 2024, March 15, 2024, April 19, 2024, and May 7, 2024, but only to the extent that the items therein are specifically stated to be “filed” rather than “furnished”
for the purposes of Section 18 of the Exchange Act; and |
| (f) | The description of our Common Stock contained in Exhibit 4.2 to the Annual Report on Form 10-K for the
year ended December 31, 2019, as filed with the Commission on April 3, 2020, including any amendment or report filed for the purpose of
updating such description. |
In addition, all documents subsequently filed
with the Commission by us pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act, prior to the filing of a post-effective
amendment which indicates that all securities offered have been sold or which deregisters all securities then remaining unsold, shall
be deemed to be incorporated by reference in this Prospectus and to be a part hereof from the date of filing of such documents; except
as to any portion of any future annual or quarterly report to stockholders or document or current report furnished under Item 2.02 or
7.01 of Form 8-K that is not deemed “filed” under such provisions. Any statement contained in a document incorporated or deemed
to be incorporated by reference herein shall be deemed to be modified or superseded for purposes of this Prospectus to the extent that
a statement contained herein or in any other subsequently filed document which also is deemed to be incorporated by reference herein modifies
or supersedes such statement. Any such statement so modified or superseded shall not be deemed, except as so modified or superseded, to
constitute a part of this Prospectus. Under no circumstances will any information furnished under Item 2.02 or 7.01 of Form 8-K be deemed
incorporated herein by reference unless such Form 8-K expressly provides to the contrary.
You should rely only on the information provided
or incorporated by reference in this Prospectus or any related prospectus. We have not authorized anyone to provide you with different
information. You should not assume that the information in this Prospectus or any related prospectus is accurate as of any date other
than the date on the front of the document.
WHERE YOU CAN FIND MORE INFORMATION
We file annual, quarterly and other reports, proxy
statements and other information with the Commission. Our filings are available to the public over the Internet at the Commission’s
website at www.sec.gov. Our Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K, including
any amendments to those reports, and other information that we file with or furnish to the Commission pursuant to Section 13(a) or 15(d)
of the Exchange Act can also be accessed free of charge by linking directly from our website at www.paysign.com. These filings
will be available as soon as reasonably practicable after we electronically file such material with, or furnish it to, the Commission.
Information contained on our website is not part of this Prospectus.
We hereby undertake to provide without charge
to each person, including any beneficial owner, to whom a copy of this Prospectus is delivered, upon written or oral request of any such
person, a copy of any and all of the information that has been incorporated by reference in this Prospectus but not delivered with the
Prospectus other than the exhibits to those documents, unless the exhibits are specifically incorporated by reference into the information
that this Prospectus incorporates. Requests for documents should be directed to our Corporate Secretary, Robert Strobo, Esq., at 2615
St. Rose Parkway, Henderson, Nevada 89052.
PART I
INFORMATION REQUIRED IN THE
SECTION 10(a) PROSPECTUS
Items 1 and 2, and the documents incorporated
by reference in this Registration Statement pursuant to Item 3 of Part II of this prospectus, taken together, constitute a prospectus
that meets the requirements of Section 10(a) of the Securities Act of 1933, as amended (the “Securities Act”).
Item 1. Plan Information.
The documents containing the information specified
in this Item 1 will be sent or given to participants of the Paysign, Inc. 2023 Equity Incentive Plan (the “Plan”) as specified
by Rule 428(b)(1) under the Securities Act. In accordance with the rules and regulations of the Securities and Exchange Commission (the
“Commission”) and the instructions to Form S-8, such documents are not being filed with the Commission either as part of this
Registration Statement or as prospectuses or prospectus supplements pursuant to Rule 424 under the Securities Act.
Item 2. Registrant Information and Employee Plan Annual Information.
The documents containing the information specified
in this Item 2 and incorporated by reference in Item 3 of Part II of this Registration Statement will be sent or given to participants
of the Plan, without charge, upon written or oral request, as specified by Rule 428(b)(1) under the Securities Act. The request shall
be directed to our Corporate Secretary, Robert Strobo, Esq., at 2615 St. Rose Parkway, Henderson, Nevada 89052 or by telephone at (702)
453-2221. In accordance with the rules and regulations of the Commission and the instructions to Form S-8, such documents are not being
filed with the Commission either as part of this Registration Statement or as prospectuses or prospectus supplements pursuant to Rule
424 under the Securities Act.
PART II
INFORMATION REQUIRED IN THE
REGISTRATION STATEMENT
Item 3. Incorporation of Documents by Reference.
The following documents, which we have filed with
the Commission, are incorporated by reference in this Registration Statement:
| (a) | Annual Report on Form 10-K for the
year ended December 31, 2023, as filed with the Commission on March 27, 2024; |
| (b) | Quarterly Report on Form 10-Q for the quarter ended March 31, 2024, as filed
with the Commission on May 8, 2024; |
| (c) | Quarterly Report on Form 10-Q for the quarter ended June 30, 2024, as filed with the Commission on August
1, 2024; |
| (d) | Definitive Proxy Statement on Schedule 14A, as filed with the Commission on March 29, 2024; |
| (e) | Current Reports on Form 8-K as filed with the Commission on January 29, 2024, March 15, 2024, April 19, 2024, and May 7, 2024, but only to the extent that the items therein are specifically stated to be “filed” rather than “furnished”
for the purposes of Section 18 of the Exchange Act; and |
| (f) | The description of our Common Stock contained in Exhibit 4.2 to the Annual Report on Form 10-K for the
year ended December 31, 2019, as filed with the Commission on April 3, 2020, including any amendment or report filed for the purpose of
updating such description. |
In addition, all documents subsequently filed
with the Commission by us pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act, prior to the filing of a post-effective
amendment which indicates that all securities offered have been sold or which deregisters all securities then remaining unsold, shall
be deemed to be incorporated by reference in this Registration Statement and to be a part hereof from the date of filing of such documents;
except as to any portion of any future annual or quarterly report to stockholders or document or current report furnished under Item 2.02
or 7.01 of Form 8-K that is not deemed “filed” under such provisions. Any statement contained in a document incorporated or
deemed to be incorporated by reference herein shall be deemed to be modified or superseded for purposes of this Registration Statement
to the extent that a statement contained herein or in any other subsequently filed document which also is deemed to be incorporated by
reference herein modifies or supersedes such statement. Any such statement so modified or superseded shall not be deemed, except as so
modified or superseded, to constitute a part of this Registration Statement. Under no circumstances will any information furnished under
Item 2.02 or 7.01 of Form 8-K be deemed incorporated herein by reference unless such Form 8-K expressly provides to the contrary.
You should rely only on the information provided
or incorporated by reference in this Registration Statement or any related prospectus. We have not authorized anyone to provide you with
different information. You should not assume that the information in this Registration Statement or any related prospectus is accurate
as of any date other than the date on the front of the document.
Item 4. Description of Securities.
Not applicable.
Item 5. Interests of Named Experts and Counsel.
Not applicable.
Item 6. Indemnification of Directors and Officers.
We are a Nevada corporation. Section 78.7502 of
Chapter 78 of the Nevada Revised Statutes (“NRS”) empowers a corporation to indemnify any person who was or is a party or
is threatened to be made a party to any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative
or investigative, except an action by or in the right of the corporation, by reason of the fact that the person is or was a director,
officer, employee or agent of the corporation, or is or was serving at the request of the corporation as a director, officer, employee
or agent of another corporation, partnership, joint venture, trust or other enterprise or as a manager of a limited-liability company,
against expenses, including attorneys’ fees, judgments, fines and amounts paid in settlement actually and reasonably incurred by
the person in connection with the action, suit or proceeding if the person (a) is not liable pursuant to NRS Section 78.138; or (b) acted
in good faith and in a manner he or she reasonably believed to be in or not opposed to the best interests of the corporation, and, with
respect to any criminal action or proceeding, had no reasonable cause to believe the conduct was unlawful. Under NRS Section 78.138, a
director or officer is not individually liable to the corporation unless such person breached their fiduciary duty and such breach involved
intentional misconduct, fraud or a knowing violation of law. If the action or suit is by or in the right of the corporation, indemnification
may not be made for any claim, issue or matter as to which such a person has been adjudged by a court of competent jurisdiction, after
exhaustion of all appeals therefrom, to be liable to the corporation or for amounts paid in settlement to the corporation, unless and
only to the extent that the court in which the action or suit was brought or other court of competent jurisdiction determines upon application
that in view of all the circumstances of the case, the person is fairly and reasonably entitled to indemnity for such expenses as the
court deems proper.
Under Article V.B of our Amended and Restated
Articles of Incorporation, we are required to indemnify, to the fullest extent permitted by Nevada law, its officers and directors. Furthermore,
Article V.C of our Amended and Restated Articles of Incorporation, we are required to pay (or through insurance purchased and maintained
by us or through other financial arrangements) any expenses of an officer or director as they are incurred and in advance of the final
disposition of a civil or criminal action, suit or proceeding, upon receipt of an undertaking by or on behalf of the director or officer
to repay the amount if it is ultimately determined by a court of competent jurisdiction that he or she is not entitled to be indemnified
by the corporation.
Under Article VII of our Amended and Restated
Bylaws, we are required to indemnify and hold harmless, to the fullest extent permitted by Nevada law, each director or officer who was
or is a party to, or is threatened to be made a party to, or is otherwise involved in, any threatened, pending, or completed action, suit
or proceeding, by reason of the fact that he or she is or was a director or officer or member, manager, or managing member of a predecessor
limited liability company or affiliate of such limited liability company, or is or was serving in any capacity at our request as a director,
officer, employee, agent, partner, member, manager, or fiduciary of, or in any other capacity for, another corporation or any partnership,
joint venture, limited liability company, trust, or other enterprise or affiliate. Indemnification may not be made to or on behalf of
an indemnitee if a final adjudication establishes that his or her acts or omissions involved intentional misconduct, fraud, or a knowing
violation of law and was material to the cause of action. Furthermore, we are required to advance expenses to an indemnitee in advance
of a final disposition of the proceeding.
The indemnification provided by our Amended and
Restated Articles of Incorporation and Amended and Restated Bylaws is not exclusive of any rights to which those indemnified may be entitled
under any agreement, vote of stockholders or disinterested directors or otherwise, both as to action in his official capacity and as to
action in another capacity while holding such office, and shall continue as to a person who has ceased to be a director, officer, employee,
or agent and shall inure to the benefit of the heirs, executors, and administrators of such a person.
Insofar as indemnification for liabilities arising
under the Securities Act may be permitted to directors, officers and controlling persons of our company pursuant to the Nevada law, our
Amended and Restated Articles of Incorporation, our Amended and Restated Bylaws or any of our indemnification agreements with our directors
and officers, we have been informed that in the opinion of the Commission such indemnification is against public policy as expressed in
the Securities Act and is therefore unenforceable.
We maintain a Directors’ and Officers’
Liability Insurance Policy designed to reimburse us for any covered payments made by us pursuant to the foregoing indemnification.
Item 7. Exemption from Registration Claimed.
Not applicable.
Item 8. Exhibits.
_______________
* Filed herewith.
| (1) | Incorporated by reference to Exhibit 10.1 to our Current Report on Form 8-K filed on May 9, 2023 (File
Number 001-38623). |
Item 9. Undertakings.
A. The undersigned registrant hereby undertakes:
(1)
To file, during any period in which offers or sales are being made, a post-effective amendment to this Registration Statement:
(i)
To include any prospectus required by Section 10(a)(3) of the Securities Act;
(ii) To reflect in the prospectus
any facts or events arising after the effective date of this Registration Statement (or the most recent post-effective amendment thereof)
which, individually or in the aggregate, represent a fundamental change in the information set forth in this Registration Statement.
Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered
would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be
reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and
price represent no more than 20 percent change in the maximum aggregate offering price set forth in the “Calculation of Registration
Fee” table in the effective registration statement; and
(iii)
To include any material information with respect to the plan of distribution not previously disclosed in this Registration Statement
or any material change to such information in this Registration Statement;
provided, however, that paragraphs (A)(1)(i)
and (A)(1)(ii) of this section do not apply if the information required to be included in a post-effective amendment by those paragraphs
is contained in reports filed with or furnished to the Commission by the registrant pursuant to Section 13 or 15(d) of the Exchange Act
that are incorporated by reference in this Registration Statement.
(2)
That, for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed
to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall
be deemed to be the initial bona fide offering thereof.
(3)
To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at
the termination of the offering.
B.
The undersigned registrant hereby undertakes that, for purposes of determining any liability under the Securities Act, each filing
of the registrant’s annual report pursuant to Section 13(a) or Section 15(d) of the Exchange Act (and, where applicable, each filing
of an employee benefits plan’s annual report pursuant to Section 15(d) of the Exchange Act) that is incorporated by reference in
this Registration Statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering
of such securities at that time shall be deemed to be the initial bona fide offering thereof.
C.
Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling
persons of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that, in the opinion of
the Commission, such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In
the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or
paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted
by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the
opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question
whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication
of such issue.
SIGNATURES
Pursuant to the requirements of the Securities
Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form
S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City
of Henderson, State of Nevada, on October 30, 2024.
| |
PAYSIGN, INC. |
| |
|
|
| |
By: |
/s/ Mark R. Newcomer |
| |
|
Mark R. Newcomer |
| |
|
Chief Executive Officer |
POWER OF ATTORNEY
KNOW ALL PERSONS BY THESE PRESENTS, that each
person whose signature appears below constitutes and appoints Mark R. Newcomer and Robert Strobo, and each of them, as
his or her true and lawful attorney-in-fact and agents, with full power of substitution and resubstitution, for him or her and in his
or her name, place, and stead, in any and all capacities, to sign any and all amendments (including post-effective amendments) to this
Registration Statement, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities
and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform
each and every act and thing requisite and necessary to be done in connection therewith, as fully to all intents and purposes as he or
she might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or any of them, or their
or his or her substitute or substitutes, may lawfully do or cause to be done by virtue hereof.
Pursuant to the requirements
of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates
indicated.
|
Signature |
Title |
Date |
| |
|
|
|
/s/ Mark R.
Newcomer |
Chief Executive Officer, Director and Chairman
(Principal Executive Officer) |
October 30, 2024 |
| Mark R. Newcomer |
| |
|
|
|
/s/ Jeff Baker |
Chief Financial Officer and Treasurer
(Principal Financial Officer and Principal Accounting Officer) |
October 30, 2024 |
| Jeff Baker |
| |
|
|
|
/s/ Matthew
Lanford |
President, Chief Operating Officer and Director |
October 30, 2024 |
| Matthew Lanford |
| |
|
|
|
/s/ Joan M.
Herman |
Executive Vice President and Director |
October 30, 2024 |
| Joan M. Herman |
| |
|
|
|
/s/ Dan R.
Henry |
Director |
October 30, 2024 |
| Dan R. Henry |
| |
|
|
|
/s/ Bruce
Mina |
Director |
October 30, 2024 |
| Bruce Mina |
| |
|
|
|
/s/ Jeffrey
B. Newman |
Director |
October 30, 2024 |
| Jeffrey B. Newman |
| |
|
|
|
/s/ Dennis
Triplett |
Director |
October 30, 2024 |
| Dennis Triplett |
Exhibit 5.1
October 30, 2024
Paysign, Inc.
2615 St. Rose Parkway
Henderson, Nevada 89052
| Re: | Registration Statement on Form S-8
Paysign, Inc. |
Ladies and Gentlemen:
As legal counsel to Paysign,
Inc., a Nevada corporation (the “Company”), we have assisted in the preparation of the Company’s Registration
Statement on Form S-8 (the “Registration Statement”), to be filed with the Securities and Exchange Commission on or
about October 30, 2024, in connection with the registration under the Securities Act of 1933, as amended, of (i) 420,000 shares of the
Company’s common stock, par value $0.001 per share (“Common Stock”), that will be issued upon the vesting of
restricted stock awards granted under the Company’s 2023 Equity Incentive Plan (the “Plan”), and (ii) 160,000
shares of Common Stock reserved for future issuance pursuant to awards that may be granted under the Plan (collectively, the “Shares”).
The facts, as we understand them, are set forth in the Registration Statement.
With respect to the opinion
set forth below, we have examined originals, certified copies, or copies otherwise identified to our satisfaction as being true copies,
only of the following:
| A. | The Amended and Restated Articles of Incorporation of the Company; |
| | | |
| B. | The Amended and Restated Bylaws of the Company; |
| | | |
| C. | Various resolutions of the Board of Directors and the Compensation Committee of the Company adopting the
Plan and authorizing the issuance of the Shares; |
| | | |
| D. | The Plan; |
| | | |
| E. | Various restricted stock agreements; and |
| | | |
| F. | The Registration Statement. |
Subject to the assumptions
that (i) the documents and signatures examined by us are genuine and authentic, and (ii) the persons executing the documents examined
by us have the legal capacity to execute such documents, and subject to the further limitations and qualifications set forth below, based
solely upon our review of items A through F above, it is our opinion that the Shares will be validly issued, fully paid, and nonassessable
when issued and sold in accordance with the terms of the Plan and the Registration Statement.
We express no opinion as to
the applicability or effect of any laws, orders, or judgments of any state or other jurisdiction other than federal securities laws and
the substantive laws of the state of Nevada, including judicial interpretations of such laws. Further, our opinion is based solely upon
existing laws, rules, and regulations, and we undertake no obligation to advise you of any changes that may be brought to our attention
after the date hereof.
We hereby expressly consent
to any reference to our firm in the Registration Statement, inclusion of this Opinion as an exhibit to the Registration Statement, and
to the filing of this Opinion with any other appropriate governmental agency.
| |
Very truly yours, |
| |
|
| |
/s/ Greenberg Traurig, LLP |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in this Registration Statement
on Form S-8 of Paysign, Inc. of our report dated March 27, 2024, relating to the consolidated financial statements, appearing in
the Annual Report on Form 10-K of Paysign, Inc. for the year ended December 31, 2023, filed with the Securities and Exchange
Commission. We also consent to the reference to us under the heading “Experts” in such Registration Statement.
/s/ Moss Adams LLP
Dallas, Texas
October 30, 2024
Exhibit 107
Calculation
of Filing Fee Tables
Form S-8
(Form
Type)
Paysign,
Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered Securities
Security
Type |
Security
Class Title |
Fee
Calculation Rule |
Amount
Registered (1) |
Proposed
Maximum Offering Price Per Unit |
Maximum
Aggregate Offering Price |
Fee
Rate |
Amount
of Registration Fee |
| Equity |
Common
Stock, par value $0.001 per share |
457(c)
and 457(h) |
420,000
(2) |
$3.72
(3) |
$1,562,400
(3) |
0.00015310 |
$239.20 |
| Equity |
Common
Stock, par value $0.001 per share |
457(c)
and 457(h) |
160,000
(4) |
$3.72
(3) |
$595,200
(3) |
0.00015310 |
$91.13 |
| Total
Offering Amounts |
|
|
$2,157,600 |
|
$330.33 |
| Total
Fee Offsets |
|
|
|
|
— |
| Net
Fee Due |
|
|
|
|
$330.33 |
| |
|
|
|
|
|
|
|
|
| (1) | Pursuant to Rule 416(a) promulgated under the Securities Act of 1933, as amended (the “Securities
Act”), this Registration Statement shall also cover any additional shares of Paysign, Inc. (the “Registrant”) common
stock, par value $0.001 per share (“Common Stock”), that may become issuable by reason of any stock dividend, stock split,
recapitalization, or any other similar transaction that results in an increase in the number of outstanding shares of Common Stock of
the Registrant. |
| (2) | Represents shares of Common Stock issued or issuable pursuant to the vesting of restricted stock awards
issued under the Paysign, Inc. 2023 Equity Incentive Plan (the “Plan”). |
| (3) | Pursuant to Rule 457(c) and 457(h) under the Securities Act, the proposed maximum offering price per share
and the proposed maximum aggregate offering price for the shares have been calculated solely for the purpose of computing the registration
fee on the basis of the average high and low prices of the Registrant’s Common Stock as reported by the Nasdaq Stock Market LLC
on October 23, 2024. |
| (4) | Represents shares of Common Stock authorized for issuance under the Plan. This Registration Statement
does not include 4,420,000 shares of Common Stock authorized for issuance under the Plan that were previously registered by the Registrant. |
Paysign (NASDAQ:PAYS)
Historical Stock Chart
From Nov 2024 to Dec 2024
Paysign (NASDAQ:PAYS)
Historical Stock Chart
From Dec 2023 to Dec 2024
